5 minute read
OTHER NEWS
Hellos and Goodbyes
Welcome Nisha
Nisha Rana has an extensive background in Clinical Trials management and operations . Hailing from the UK, Nisha started her career in the clinical setting as a biomedical scientist and soon found herself working as a research scientist . Passionate about delivering ground breaking research from the laboratory bench to the patient’s bedside quicker (translational research), Nisha was keen to hang up her lab coat and move into Clinical Trials management . Although having worked in a research management capacity in a host of Therapeutic Areas (TA) including: Respiratory, Oncology, Mental Health, Emergency & Critical Care, Cardiovascular and Musculoskeletal medicine; Nisha still considers herself a scientist and first and foremost, a patient! Still actively involved in developing research processes to streamline Clinical Trial set-up and running as well as managing the handling of research biological samples as part of the greater translational research efforts of ANZUP .
Welcome Evie
Lucy Byers our Marketing and Communications Manager, welcomed baby Evie Rose Patricia Byers who came into the world on Father’s Day . Here’s a photo and Mum and baby Evie and we wish Lucy, Evie, Alex and Grace all the best for their first Christmas together .
Farewell Jaclyn
In December we farewelled Jaclyn in the role of Clinical Trials Project Manager . We wish Jaclyn all the best as she takes some time to spend with her family .
Thank you Emily
We would like to thanks Emily Tu from the CTC who has worked tirelessly on the ENZAMET trial and has now handed over to Shirley Yung . Thanks for all your work over the years Emily .
Applications are now open for the position of Senior Research Fellow for the Prostate Cancer Outcomes Registry . Details for the role and applying can be found at the following link: http://careers.pageuppeople. com/513/cw/en/job/600957/senior-research-fellow-pcor.
Dr Arsha Anton was awarded the 2019 ANZUP Mundipharma Clinical Research Fellowship, and using the funds to further develop her REAL-Pro study . REAL-Pro is a Registry-based Study of Enzalutamide vs Abiraterone assessing cognitive function in ELderly patients with Metastatic Castration-Resistant Prostate Cancer . She is currently looking for additional sites to be involved in this study . For more information please click here .
Join us at #ANZUP2020 in Adelaide
It’s a pleasure to invite you to the ANZUP ASM in 2020, 19-21 July 2020 at the Adelaide Convention Centre for the first time.
Our theme for #ANZUP2020 is ‘Clear Vision’. What does Clear Vision mean for us as GU cancer professionals? It means we need to see clearly which data deserves attention, which treatments hold promise for the future, which drugs deserve to be tested in clinical trials, and most importantly it means we need to see clearly what the priorities are for our patients.
I look forward to welcoming you next year.
#ANZUP2020 Speaker Spotlight
Prof Heather Payne
We welcome Prof Heather Payne as one of our #ANZUP2020 International Faculty .
Heather Payne was appointed as a Consultant in Clinical Oncology at University College London Hospitals, London in 1997 . She trained to be a doctor at London University in St Mary’s Hospital Medical School and after qualifying spent some working in general medicine and surgery, paediatrics and psychiatry . She then travelled to work as a volunteer doctor in the Caribbean island of Haiti where conventional medicine was mixed with voodoo practices .
She returned to London to train as a Clinical Oncologist and during this time developed an interest in urological oncology . Heather now have a busy practice specialising only in the management of prostate cancer at University College London Hospitals . Her work involves the management of all stages of prostate cancer as part of a multidisciplinary team . She treats men with radiotherapy, chemotherapy, hormone therapy and is involved in clinical trials investigating novel agents . She pioneered a programme of High Dose Rate Brachytherapy for prostate cancer at University College London Hospitals which has allowed the delivery of higher and potentially more effective doses of radiotherapy for men with high risk or locally advanced prostate cancer . The academic challenges of these new technologies are fascinating, but this is balanced with a very human side to the job and that is in caring for men and their families at a very difficult time . Heather was appointed as a professor of prostate oncology at University College London which has led to many collaborations and research in the departments of physics, nuclear medicine, pharmacology and radiology . She is the Principle Investigator in a number of international multi-centre and local studies . Heather is the chair of the British Uro-oncology Group (BUG) which she started as a professional organisation to support oncologists with a specialised interest in urological tumours . She also serves on the Prostate Cancer Charter for Action the Department of Health Prostate Cancer Advisory Group for the United Kingdom and is the Oncology Clinical Lead for the National Prostate Cancer audit .
Heather’s main areas of research are prostate radiotherapy and brachytherapy and the treatment of castration resistant prostate cancer . She is also involved in a number of studies looking at quality of life form men with prostate cancer and have a special interest in erectile dysfunction for men with advanced disease .
ANNUAL SCIENTIFIC MEETING
ADELAIDE CONVENTION CENTRE 19-20 JULY 2020
